US Patent 9566318 Combination therapy
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+179 characters)
Article
Patent abstract
The invention relates to producing humoral response to P2X7 receptors in individuals having cancer, and to minimizing the progression of cancer in said individuals.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Angus Gidley-Baird0
Julian Alexander Barden0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09566318 Combination therapy US Patent 9566318 Combination therapy
Infobox
Patent Number
095663180
Patent Number
95663180
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
095663180
Date of Patent
February 14, 2017
0Patent Application Number
141292400
Date Filed
July 2, 2012
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09566318 Combination therapy
Infobox
Is a
Patent jurisdiction
Patent number
09566318
Date of patent
February 14, 2017
Patent application number
14129240
Date Filed
July 2, 2012
Patent primary examiner
Find more entities like US Patent 9566318 Combination therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
